AGF Investments America’s AbbVie ABBV Stock Holding History

AGF Investments America’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-78,510	Closed	-$12.7M	–	28
2022 Q1	$12.7M	Buy	78,510 +37,436	+91%	+$5.44M	2.32%	16
2021 Q4	$5.56M	Buy	41,074 +977	+2%	+$115K	1.06%	32
2021 Q3	$4.33M	Hold	40,097	–	–	0.9%	34
2021 Q2	$4.52M	Buy	40,097 +852	+2%	+$96K	1.07%	34
2021 Q1	$4.25M	Hold	39,245	–	–	1.07%	35
2020 Q4	$4.21M	Buy	39,245 +36	+0.1%	+$3.46K	1.09%	34
2020 Q3	$3.43M	Buy	39,209 +475	+1%	+$44.7K	1.03%	38
2020 Q2	$3.8M	Buy	38,734 +1,311	+4%	+$115K	1.3%	32
2020 Q1	$2.85M	Buy	37,423 +534	+1%	+$45.5K	1.19%	32
2019 Q4	$3.27M	Buy	36,889 +327	+0.9%	+$27.1K	1.08%	34
2019 Q3	$2.77M	Buy	36,562 +701	+2%	+$48.1K	0.92%	35
2019 Q2	$2.61M	Buy	35,861 +654	+2%	+$51.4K	0.89%	40
2019 Q1	$2.84M	Buy	35,207 +2,344	+7%	+$192K	1.01%	35
2018 Q4	$3.03M	Buy	32,863 +795	+2%	+$69.9K	1.23%	31
2018 Q3	$3.03M	Buy	32,068 +528	+2%	+$50.1K	1.05%	35
2018 Q2	$2.92M	Buy	31,540 +732	+2%	+$71.5K	1.08%	36
2018 Q1	$2.92M	Buy	30,808 +564	+2%	+$62K	1.11%	35
2017 Q4	$2.92M	Buy	30,244 +817	+3%	+$77K	1.09%	37
2017 Q3	$2.62M	Buy	29,427 +363	+1%	+$27.6K	1%	39
2017 Q2	$2.11M	Buy	29,064 +1,017	+4%	+$68.4K	0.83%	41
2017 Q1	$1.83M	Buy	28,047 +489	+2%	+$30.7K	0.75%	49
2016 Q4	$1.73M	Buy	27,558 +342	+1%	+$20.9K	0.74%	47
2016 Q3	$1.72M	Buy	27,216 +97	+0.4%	+$6.28K	0.75%	46
2016 Q2	$1.68M	Buy	+27,119	New	+$1.65M	0.76%	46

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

AGF Investments America's ABBV Position: Q2 2022 in Review

AGF Investments America sold out of AbbVie (ABBV) in Q2 2022, closing a stake of 78,510 shares — an estimated $12.7M sold.

AGF Investments America first reported a position in ABBV in Q2 2016 and held it in 24 quarters. The position peaked at $12.7M in Q1 2022. 3,005 funds tracked by Wall St. Rank hold ABBV as of Q2 2022.

AGF Investments America reported no remaining AbbVie position as of Q2 2022 after selling out during the quarter.
AGF Investments America sold 78,510 AbbVie shares in Q2 2022, an estimated $12.7M.
AGF Investments America first reported a position in AbbVie in Q2 2016 and held it in 24 quarters.
AGF Investments America's AbbVie position peaked at $12.7M in Q1 2022.
3,005 funds tracked by Wall St. Rank held AbbVie as of Q2 2022.

Based on AGF Investments America's 13F filing for Q2 2022, filed 12 Aug 2022.